Our ambition is for Greater Manchester, one of the UK’s three biomedical clusters, to become a world-leading location for clinical research.
The region’s single health and social care system is now providing greater impetus to deliver clinical research at pace and scale, where every patient is provided with the opportunity to be involved in research because it is at the heart of our innovative clinical practice. This will deliver both better health outcomes and economic growth.
In taking our research ambitions forward, we are supported by first-rate people, services and infrastructure. This ranges from an internationally recognised NIHR biomedical research centre and clinical research facility, through to bespoke services, designed to support and facilitate the research process, for example, the Greater Manchester Research Hub and our Clinical Trials Unit.
Health Innovation Manchester is a centre of excellence, strength and depth in experimental medicine and translational research.
Research within experimental medicine spans fundamental discovery science to translational approaches, which include early phase clinical trials.
Our strategic approach to research is through the lens of P4 Medicine: to prevent disease, predict disease progression, personalise treatment pathways and empower patients to participate in their healthcare.
This P4 Medicine approach is applied through all our research and cross-cutting themes (as shown in the diagram) to provide opportunities for sharing expertise and discoveries, in order to deliver efficient experimental research that maximises synergies across our partnership and accelerates discoveries through to routinely commissioned care